About
Trellis AI builds healthcare-native AI agents that automate intake, benefits and reimbursement workflows, prior authorizations, appeals, and related pre-service operations. It sells to healthcare providers, including specialty providers, infusion providers, and specialty pharmacies, differentiating through direct EHR integration, structured-data extraction from messy clinical documents, and end-to-end workflow execution that can shorten time to treatment and increase revenue.
Market
Trellis competes in healthcare administrative automation and medication-access software, particularly the market for AI-enabled intake, prior authorization, appeals, and treatment-acceleration workflows. It positions itself as an AI-native healthcare network with self-improving agents that operate across the full care journey rather than as a single-purpose authorization tool. Its differentiation is the combination of workflow replication, proprietary-system learning, EHR and payer-portal execution, document processing, and outbound calls; the named alternatives in the evidence primarily emphasize prior-authorization or medication-access automation.
Trellis’s ideal customers are healthcare provider organizations—especially specialty providers and larger, high-volume organizations—that need to automate pre-service, medication-access, and administrative workflows. Likely buyers are operations, patient-access, revenue-cycle, and authorization teams, since the product integrates with EHR workflows and targets paperwork reduction, faster treatment, and improved reimbursement.
At a Glance
Problem
Healthcare providers, especially specialty pharmacies and infusion centers, lose time and revenue to fragmented pre-service administration. Prior authorizations, appeals, referrals, benefits checks, and supporting documentation are manual, slow, error-prone bottlenecks that delay treatment, increase denials and revenue leakage, and contribute to staff burnout. Trellis cites administrative costs exceeding 20% of U.S. healthcare spending, while its core use case is compressing the journey from a messy referral to an approved therapy, particularly for high-cost specialty medications and infusions.
Product / Service
Trellis is an enterprise healthcare-automation platform that embeds AI agents into providers’ existing workflows. Its agents extract information from referrals, faxes, PDFs, scans, EHRs, and lab records; validate medical necessity against payer requirements; generate and submit authorization forms through payer portals; track status; identify discrepancies; automate appeals; and keep patients informed. The system is designed to work without forcing teams to redesign their internal processes, while its stated benefits are faster time-to-treatment, greater operational volume without proportional headcount, higher first-pass approval rates, and improved revenue capture.
Market
Trellis competes in healthcare AI infrastructure and administrative-automation, with an initial focus on medication access for specialty providers, specialty pharmacies, office infusion centers, and national infusion groups. Overlapping competitors include Forus, which generates and submits prior authorizations; Infinitus, which automates phone-based prior-authorization follow-up; and Tandem, which covers the prior-authorization and medication-access journey from prescription to delivery. Trellis differentiates itself by combining document intake, benefits and reimbursement workflows, authorization submission, appeals, and broader care-journey orchestration in one healthcare-native agent platform.
The company is an active YC Winter 2024 startup founded in 2024, with 34 employees listed by YC, and is described as a Stanford AI Lab spinout backed by YC, General Catalyst, Telesoft Partners, and technology executives. Its LinkedIn presence reports partnerships with national infusion and specialty-pharmacy groups and automation across billions of dollars in therapies, while company pages report outcomes such as roughly 90% faster time to treatment, 5x FTE productivity gains, and a 10-minute referral-to-PA workflow. The evidence establishes meaningful deployment and partnership signals, but does not disclose revenue or a confirmed count of paying customers, so Trellis is best characterized as commercially active with revenue status undisclosed rather than definitively pre-revenue.
Founders & Leadership
Funding History
Y Combinator
Recent News
Trellis presented its AI-native healthcare network, embedding agents across the care journey to automate work from clinical-data extraction and medical-necessity letters through prior authorizations, denials, patient-assistance programs, and clinical-trial enrollment.
Trellis introduced an AI-powered prior-authorization agent that searches guidelines, extracts required information from EHRs and labs, completes and submits forms to payer portals, flags discrepancies, and automates appeals. The product page also describes medical-necessity validation, status tracking, and denial-prevention features.
Trellis announced a healthcare workflow product that automates document intake, prior authorizations, and appeals, converting unstructured clinical documents into structured EHR data and integrating directly into EHR workflows.
Active Roles
7Business Model
Trellis AI makes money through B2B contracts with healthcare organizations for its AI-agent automation platform, targeting providers that want to reduce administrative work, accelerate treatment, and improve reimbursement and revenue. Its public materials use a demo-led sales motion and do not disclose a specific pricing structure.